Avid Bioservices to Participate at BIO International Convention 2018 - Seite 2

Additionally, Avid will dedicate a portion of its booth to celebrating the company’s 25 years of experience in biopharmaceutical development and manufacturing, which dates back to 1993.  This anniversary coincides with the 25-year anniversary of the Biotechnology Innovation Organization (BIO), which is also being celebrated this year. 

• Joining the Avid team at BIO 2018 will be Sandra C. Carbonneau, the company’s newly appointed director of business development for the East Coast.  Mrs. Carbonneau has more than 26 years of relevant industry experience, including a 22-year tenure with Lonza, a global integrated solutions provider to the pharmaceutical and biotechnology industries.  During her time with Lonza, she held positions of increasing responsibility spanning areas of manufacturing, quality assurance, compliance and contract management, culminating in her overseeing the company’s global commercial development for its mammalian business unit.  Mrs. Carbonneau most recently served as director of business development in the New England region at Integrated Project Services (IPS), a leading consulting firm for technically complex facilities worldwide. At Avid, she will play a key role in the company’s new customer acquisition efforts on the east coast of the US, while supporting all its existing clients in the eastern half of the country.
   
• Roger Lias, Ph.D., Avid’s president and chief executive officer, will participate in a roundtable discussion titled, “Capacity Strategies – The Strategy Behind the Large Scale SUS vs. Stainless Steel Investment.”  The roundtable discussion will take place from 1:00 – 2:00 p.m. Eastern on Wednesday, June 6^th at booth #375 within the BioProcess Zone’s BPI Theatre.  It will be part of the BPI Theatre’s “Emerging Techniques, Technologies and Strategies” track.
   
• Sun Ra Bullins, director of manufacturing at Avid, will make a presentation titled, “The Perks and Pitfalls of a Single-Use Biopharmaceutical Facility.”  The presentation will take place from 3:40 – 4:00 p.m. Eastern on Wednesday, June 6th at booth #375 within the BioProcess Zone’s BPI Theatre.  It will be part of the BPI Theatre’s “Emerging Techniques, Technologies and Strategies” track.

For more information on the BIO International Convention, please visit: http://convention.bio.org/.

About Avid Bioservices, Inc.
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.  The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.  With 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid's services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support.  The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.  www.avidbio.com

Contacts:
Kelly Pisarev Lord
Avid Bioservices, Inc.
[phone]

Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
[e-mail]

Tim Brons (Media)
Vida Strategic Partners  
415-675-7402
[e-mail]